US equities |
META $630.56 ▲+0.00% MU $903.70 ▲+0.00% NVDA $216.00 ▲+0.00% TSLA $391.62 ▲+0.00% INTC $90.47 ▲+0.00% SPCX $146.90 ▲+0.00% AMD $531.28 ▲+0.00% SNDK $1,255.58 ▲+0.00%
FinancialContent

Establishment Labs Holdings Inc. - Common Shares (NQ:ESTA)

65.78 UNCHANGED
Delayed Quote Updated: 4:00 PM EDT, Oct 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Establishment Labs Holdings Inc. - Common Shares

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
Establishment Labs to Announce First Quarter 2023 Financial Results on May 8
From Establishment Labs Holdings Inc.
Via Business Wire
News headline image
Establishment Labs Announces Pricing of Public Offering of Common Shares
From Establishment Labs Holdings Inc.
Via Business Wire
News headline image
Establishment Labs Announces Proposed Public Offering of Common Shares
From Establishment Labs Holdings Inc.
Via Business Wire
News headline image
Establishment Labs Hldgs Earnings Preview ↗
 
Via Benzinga
4 Analysts Have This to Say About Establishment Labs Hldgs ↗
 
Via Benzinga
Expert Ratings for Establishment Labs Hldgs ↗
 
Via Benzinga
News headline image
Establishment Labs Announces Preliminary Unaudited Results for First Quarter 2023
From Establishment Labs Holdings Inc.
Via Business Wire
News headline image
Establishment Labs Notes Presentation of 3-Year Results from Motiva U.S. IDE Study at The Aesthetic Meeting 2023
From Establishment Labs Holdings Inc.
Via Business Wire
News headline image
Establishment Labs Begins a New Era in Breast Aesthetics with Launch of Mia Femtech in Japan
From Establishment Labs Holdings Inc.
Via Business Wire
News headline image
Establishment Labs Announces Participation in The Aesthetic Meeting 2023
From Establishment Labs Holdings Inc.
Via Business Wire
News headline image
Establishment Labs Surpasses Three Million Motiva Devices
From Establishment Labs Holdings Inc.
Via Business Wire
News headline image
Establishment Labs Announces First Mia Femtech™ Partners in Europe and Second Partner Chain in Japan
From Establishment Labs Holdings Inc.
Via Business Wire
News headline image
Establishment Labs Holdings Inc. (NASDAQ:ESTA) Investor Alert: Investigation over Potential Wrongdoing ↗
San Diego, CA -- (SBWIRE) -- 03/16/2023 -- An investigation was announced over potential breaches of fiduciary duties by certain directors at Establishment Labs Holdings Inc. 
Via SBWire
News headline image
ESTA INVESTOR NOTICE: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Establishment Labs Holdings Inc. Investors to Inquire About Securities Class Action Investigation – ESTA
From Rosen Law Firm
Via Business Wire
News headline image
Establishment Labs to Present at the Cowen 43rd Annual Health Care Conference
From Establishment Labs Holdings Inc.
Via Business Wire
News headline image
Establishment Labs Submits Module Four to U.S. FDA for Premarket Approval of Motiva and Reports Record Fourth Quarter and Full Year 2022 Financial Results
From Establishment Labs Holdings Inc.
Via Business Wire
News headline image
Establishment Labs to Announce Fourth Quarter 2022 Financial Results on February 27
From Establishment Labs Holdings Inc.
Via Business Wire
News headline image
Earnings Scheduled For February 27, 2023 ↗
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is projected to report quarterly earnings at $0.14 per share on revenue of $505.61 million. 
Via Benzinga
News headline image
Establishment Labs Announces Preliminary Unaudited Revenue for Fourth Quarter and Fiscal Year 2022
From Establishment Labs Holdings Inc.
Via Business Wire
News headline image
Establishment Labs Announces Seishin Plastic and Aesthetic Surgery Clinic in Japan as First Clinic Partner in Global Launch of Mia Femtech™
From Establishment Labs Holdings Inc.
Via Business Wire
News headline image
ESTABLISHMENT LABS ALERT: Bragar Eagel & Squire, P.C. is Investigating Establishment Labs Holdings Inc. on Behalf of Establishment Labs Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Goldman Sachs To $492? Here Are 10 Other Price Target Changes For Wednesday ↗
 
Via Benzinga
News headline image
Establishment Labs to Participate in 41st Annual J.P. Morgan Healthcare Conference
From Establishment Labs Holdings Inc.
Via Business Wire
News headline image
Bragar Eagel & Squire, P.C. Is Investigating EyePoint, F45, PROG, and Establishment and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Bragar Eagel & Squire, P.C. Is Investigating Establishment, Accelerate Diagnostics, Instil and Unisys and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Establishment Labs Announces Japanese Regulatory Approval and Reimbursement for Motiva Implants and the Motiva Flora Tissue Expander for Use in Post-Mastectomy Reconstruction
From Establishment Labs Holdings Inc.
Via Business Wire
News headline image
Establishment Labs Reports Third Quarter 2022 Financial Results
From Establishment Labs Holdings Inc.
Via Business Wire
News headline image
Bragar Eagel & Squire, P.C. Is Investigating PROG, Tattooed Chef, and Establishment and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Earnings Preview: Establishment Labs Hldgs ↗
Establishment Labs Hldgs (NASDAQ:ESTA) is set to give its latest quarterly earnings report on Monday, 2022-11-07. Here's what investors need to know before the announcement. Analysts estimate that... 
Via Benzinga
News headline image
Establishment Labs Holdings Inc. (NASDAQ:ESTA) Investor Notice: Investigation over Possible Violations of Securities Laws ↗
San Diego, CA -- (SBWIRE) -- 11/02/2022 -- Establishment Labs Holdings Inc. is under investigation over potential securities laws violations in connection with certain financial statements. 
Via SBWire
< Previous 1 2 3 4 5 6 7 8 9 Next >